Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04072952
Title A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (mBC)
Acronym mBC
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Arvinas Estrogen Receptor, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Clinical Trial Site Palo Alto California 94304 United States Details
Clinical Trial Site San Francisco California 94158 United States Details
Clinical Trial Site Santa Monica California 90404 United States Details
Clinical Trial Site Norwalk Connecticut 06856 United States Details
Clinical Trial Site Fort Myers Florida 33901 United States Details
Clinical Trial Site Tampa Florida 33612 United States Details
Clinical Trial Site Chicago Illinois 60637 United States Details
Clinical Trial Site Boston Massachusetts 02114 United States Details
Clinical Trial Site Boston Massachusetts 02215 United States Details
Clinical Trial Site Ann Arbor Michigan 48109 United States Details
Clinical Trial Site Saint Louis Missouri 63110 United States Details
Clinical Trial Site East Brunswick New Jersey 08816 United States Details
Clinical Trial Site Bronx New York 10461 United States Details
Clinical Trial Site Charlotte North Carolina 28204 United States Details
Clinical Trial Site Nashville Tennessee 37203 United States Details
Clinical Trial Site Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field